By MedClinRes.org Clinical Research Team. Last updated September 30, 2026.
Before trusting a clinical study to answer your own question, check one thing first: did the study actually include people like you? Every clinical study is built around a specific group of people, defined by inclusion criteria (who is allowed to join) and exclusion criteria (who is kept out). Those rules decide who a study's results can honestly describe — and just as important, who they cannot.
This guide explains what inclusion and exclusion criteria are, why researchers set them, and how to check whether a study's population resembles the situation you're trying to understand. It ends with a short checklist you can use on any study you read.
What Inclusion and Exclusion Criteria Actually Are
The NIH's Toolkit for Clinical Research defines eligibility criteria in two parts: inclusion criteria, the medical or social characteristics a person must have to join a study, and exclusion criteria, the characteristics that keep someone out.[1] A person has to satisfy every inclusion criterion and avoid every exclusion criterion to be enrolled.
Those criteria are written into the study protocol before enrollment begins, and they exist to make sure participants are alike on the factors that matter for interpreting the result — commonly age, the disease or stage of disease being studied, general health, and prior treatment.[2] A given study record will spell out its own specific cutoffs and requirements for each of those factors; they are not the same from one study to the next.
Why Studies Narrow Their Population on Purpose
Eligibility criteria aren't red tape. Researchers set them so that the people in a study are similar enough to each other that any difference in outcome can be reasonably attributed to the treatment being tested, rather than to differences among the participants themselves.[2] A tightly defined population also makes a study safer to run: it can exclude people for whom a treatment carries known risk, or who have other conditions that would make results hard to interpret.
That same narrowing shows up differently depending on where a study sits in the research pipeline. Early-phase drug studies typically enroll a small number of healthy volunteers to check safety, while later-phase studies enroll larger, more varied groups of patients who actually have the condition being treated.[3] A vaccine study, for example, may start in adults and only move into progressively younger age groups once earlier results support it.[3] The population a study describes is a moving target, not a fixed one.
Why the Same Narrowing Limits Who the Results Describe
The flip side of a well-controlled study population is a well-defined limit on generalizability. A finding that holds in the group actually studied does not automatically hold in a different group. Field trial methodology literature gives a concrete example: results from trials conducted in high-income countries may not transfer directly to low- and middle-income countries, because of differences such as the prevalence of other infections or nutritional deficiencies in the local population.[3] The same logic applies closer to home — a study population defined by a narrow age range, a specific diagnosis definition, or a particular care setting describes that population, not everyone who shares the same general condition.
This is not a flaw in the study. It's a description of its boundaries. The practical task for a reader is to identify those boundaries and compare them to their own situation before deciding how much weight to give the results.
The Population-Comparison Checklist
Use this checklist on any study you're trying to apply to your own situation. It covers the five areas where a study's population most often differs from a reader's:
- Age range. Find the study's stated age eligibility, as written in that specific study's protocol or registry record, and compare it to your own age or the age of the person you're asking about. A study limited to a specific adult age band has not directly tested people outside that band, even if the condition itself affects a wider age range.[2]
- Diagnosis definition. Check exactly how the study defined the condition being studied — the diagnostic criteria, disease stage, severity threshold, or test results required to qualify. A study of “moderate” disease does not describe “mild” or “severe” disease unless it says so.
- Medicines and prior treatment. Look for exclusion criteria or baseline descriptions covering medicines participants were taking, medicines they were required to stop, or treatments they had already tried. If you're on a medicine the study excluded, or haven't tried a treatment the study required first, the population doesn't match yours.
- Setting. Note where and how the study was conducted — inpatient or outpatient, a particular country or health system, a specialty clinic versus general practice. A result from a specialized referral center does not necessarily describe what happens in routine primary care, or in a different country's health system.[3]
- Missing details. If a summary or news article doesn't state the age range, diagnosis definition, medicines, or setting, treat the comparison as unverified rather than assuming it's close enough. The original study record or published methods section is the place to look; when that information isn't available, the honest conclusion is that the match can't be confirmed.
If a study's population differs from yours on more than one of these points, treat its results as informative background rather than a direct answer to your specific question, and bring the study to a clinician or researcher who can help interpret it in your context.
Where to Find a Study's Eligibility Criteria
Every study registered with ClinicalTrials.gov has its eligibility criteria drawn from the study protocol and published as part of that study's public record. If you're starting from a news article, abstract, or press release instead of the registry record itself, the registration number (often written as an NCT number) is the fastest way to find it; our companion guide on matching a study to its registry record walks through that process. Once you're at the full study record, the eligibility criteria are stated in the researchers' own words, which is more reliable than a secondhand summary.
What This Guide Is Not
This article is a plain-language explanation of how eligibility criteria work and a checklist for comparing a study's population to your own situation. It is not medical advice, and it is not a substitute for reading a study's full published methods or eligibility criteria yourself. It does not tell you whether any specific treatment is appropriate for you. If you're weighing a treatment decision based on a clinical study, bring the study — and this checklist — to a qualified clinician or researcher who can evaluate it alongside your medical history.
Related Reading on This Site
- Clinical Trial Registration Numbers: How to Match a Study With Its Registry Record
- Randomized Trial Abstracts: How to Find the Primary Outcome and Time Frame
- Systematic Reviews and Meta-Analyses: Why Included Studies Matter
For more on how this site researches and fact-checks its guides, see our Editorial Standards and About pages.
Sources
- National Center for Advancing Translational Sciences (NCATS), National Institutes of Health. Toolkit for Clinical Research glossary: “Inclusion Criteria” and “Exclusion Criteria.”
- National Center for Advancing Translational Sciences (NCATS), National Institutes of Health. “Eligibility Criteria,” patient registries glossary.
- Smith, P.G., Morrow, R.H., Ross, D.A. (eds.) “Types of Intervention and Their Development,” in Field Trials of Health Interventions: A Toolbox, 3rd edition. National Center for Biotechnology Information, National Library of Medicine.